ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,932Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 15

$495K Total Retail Price of All Prescriptions

Rank: 5 out of 15

384 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 384 patients filled at least one prescription for a schedule two drug, compared to an average of 14%.

Schedule Three
Controlled Substances

14% of this provider’s 384 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 7,829 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $38 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
SIMVASTATIN 368 331 1 6
LISINOPRIL 337 305 2 2
LEVOTHYROXINE SODIUM 294 267 3 3
HYDROCHLOROTHIAZIDE 282 262 4 13
HYDROCODONE-ACETAMINOPHEN 280 217 S3 5 5
LOSARTAN POTASSIUM 251 239 6 25
CRESTOR 243 234 7 58
SPIRONOLACTONE 211 193 8 37
CITALOPRAM HBR 207 193 9 10
OMEPRAZOLE 184 176 10 7
AMLODIPINE BESYLATE 169 158 11 9
WARFARIN SODIUM 164 146 12 1
TAMSULOSIN HCL 159 132 13 26
METOPROLOL SUCCINATE 152 134 14 20
FUROSEMIDE 138 131 15 4
DONEPEZIL HCL 134 134 16 15
ATENOLOL 133 126 17 23
NAMENDA 121 109 18 19
ATORVASTATIN CALCIUM 120 109 19 18
ZOLPIDEM TARTRATE 119 112 20 41
CARBIDOPA-LEVODOPA 112 101 21 32
METFORMIN HCL 90 81 22 16
FINASTERIDE 83 60 23 82
DIGOXIN 80 72 24 34
RISPERIDONE 80 66 24 42
DOXAZOSIN MESYLATE 78 76 26 83
HYDROMORPHONE HCL 70 18 S2 27 115
CARVEDILOL 68 67 28 31
TRIAMTERENE-HCTZ 67 67 29 61
NEXIUM 65 64 30 122
TRAMADOL HCL 64 62 31 47
DIOVAN 64 54 31 67
PREDNISONE 63 50 33 30
FLUOXETINE HCL 63 43 33 67
BUSPIRONE HCL 62 59 35 129
AMITRIPTYLINE HCL 61 56 R 36 97
METOPROLOL TARTRATE 59 55 37 11
OXYCODONE-ACETAMINOPHEN 59 43 S2 37 94
GABAPENTIN 58 43 39 12
CLOPIDOGREL 55 53 40 50
MELOXICAM 54 46 41 139
TRAZODONE HCL 53 41 42 14
SERTRALINE HCL 51 47 43 17
FENTANYL 51 48 S2 43 35
PLAVIX 51 49 43 98
OXYCODONE HCL 50 30 S2 46 24
CIPROFLOXACIN HCL 50 48 46 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 4, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.